Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q2 2022 · 10-Q
Revenue—
Net Income-$1.69M-$1.69MN/M vs Q2 2021 EPS Diluted-$0.02-$0.02N/M vs Q2 2021 Operating Income-$1,975,964N/M Operating Cash Flowderived-$419,583N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Jan 31, 2022 · filed Mar 15, 2022 · 43 d after period end